HeartWare shares recommended at Canaccord Canaccord recommends increasing exposure to HeartWare. The firm expects HeartWare to have a very strong 2013 and notes checks in the U.S. indicate upside to current estimates. The firm rates shares a Buy and raised its price target to $144 from $107.
News For HTWR From The Last 14 Days
Check below for free stories on HTWR the last two weeks.